Microsoft (MSFT)

Retained Earnings

$328.27B

Quarterly · Period ending: · USD

MSFT logo

MSFT Retained Earnings

Latest reported$328.27B
MSFT Quarterly Retained Earnings ($89.20M → $328.27B)
High-resolution chart · PNG

MSFT retained earnings history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Microsoft Retained Earnings — Quarterly (USD)
Period endingRetained Earnings (USD)
328,265,000,000
302,526,000,000
280,789,000,000
254,873,000,000
237,731,000,000
219,759,000,000
203,482,000,000
188,929,000,000
173,144,000,000
159,394,000,000
145,737,000,000
132,143,000,000
118,848,000,000
108,234,000,000
99,368,000,000
92,374,000,000
84,281,000,000
79,633,000,000
75,045,000,000
66,944,000,000
57,055,000,000
50,735,000,000
44,973,000,000
39,193,000,000
34,566,000,000
32,012,000,000
30,739,000,000
27,240,000,000
24,150,000,000
18,338,000,000
16,585,000,000
17,279,000,000
13,682,000,000
9,974,000,000
8,567,000,000
19,702,000,000
17,769,000,000
531,000,000
120,000,000
944,000,000
2,282,000,000
4,954,000,000
6,728,000,000
7,614,000,000
9,096,000,000
18,186,000,000
19,731,000,000
18,051,000,000
17,710,000,000
16,289,000,000
14,347,000,000
11,680,000,000
9,895,000,000
7,657,000,000
4,236,000,000
932,000,000
566,000,000
3,386,000,000
219,000,000
-4,101,000,000
-8,195,000,000
-9,782,000,000
-13,165,000,000
-14,993,000,000
-16,681,000,000
-16,807,000,000
-19,605,000,000
-21,081,000,000
-23,793,000,000
-25,679,000,000
-27,499,000,000
-28,938,000,000
-27,703,000,000
-25,821,000,000
-29,725,000,000
-30,094,000,000
-31,114,000,000
-27,389,000,000
-24,518,000,000
-21,556,000,000
-20,130,000,000
-17,812,000,000
-15,932,000,000
-12,535,000,000
-13,724,000,000
-11,456,000,000
-11,171,000,000
18,799,000,000
18,429,000,000
16,605,000,000
16,667,000,000
15,382,000,000
25,676,000,000
23,950,000,000
22,207,000,000
20,503,000,000
20,533,000,000
23,396,000,000
21,373,000,000
19,209,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.